News & Updates

Show Multimedia Only
Sleep disruption after COVID tied to dyspnoea, other post-acute sequelae

Sleep disruption after COVID tied to dyspnoea, other post-acute sequelae

22 Apr 2023 byElvira Manzano

Sleep disruption following hospital admission for COVID-19 is associated with dyspnoea, anxiety, and muscle weakness in the CircCOVID cohort sub-study presented at ECCMID 2023.

22 Apr 2023
COVID-19 survivors at high risk of subsequent IBS COVID-19 survivors at high risk of subsequent IBS

COVID-19 survivors at high risk of subsequent IBS

21 Apr 2023

Individuals who have contracted COVID-19 at increased risk of developing irritable bowel syndrome (IBS) compared with those who have not been infected, as reported in a study.

21 Apr 2023
Molnupiravir speeds up recovery, reduces viral load of vaccinated COVID-19 patients

Molnupiravir speeds up recovery, reduces viral load of vaccinated COVID-19 patients

21 Apr 2023 byStephen Padilla

In vaccinated adults with COVID-19 who are at higher risk of adverse outcomes, treatment with molnupiravir in addition to usual care falls short of reducing the rates of hospitalizations and deaths, as shown by the results of the PANORAMIC study.

21 Apr 2023
Long COVID profoundly affects patients' QoL

Long COVID profoundly affects patients' QoL

21 Apr 2023 byAudrey Abella

In a functional assessment of post-COVID long-term sequelae, individuals suffering from long COVID (having at least one symptom of post-COVID-19 syndrome) had poorer quality of life (QoL) than those unaffected by the syndrome.

21 Apr 2023
COVID-19 medicine use in pregnancy increases with disease severity

COVID-19 medicine use in pregnancy increases with disease severity

19 Apr 2023

Use of medicines for COVID-19 during pregnancy is higher in patients with more severe disease, according to a study. In addition, a trend towards increased corticosteroids use has been observed and appears to be consistent with changing guidelines.

19 Apr 2023
MV-140 vaccine proven safe, effective in recurrent UTI

MV-140 vaccine proven safe, effective in recurrent UTI

18 Apr 2023 byStephen Padilla

Immunotherapy with MV-140 (Uromune) successfully prevents urinary tract infections (UTIs) in patients suffering from recurrent UTIs, suggest the results of a prospective study presented at the 38th Annual EAU Congress (EAU 2023).

18 Apr 2023